Clinical Trials Directory

Trials / Completed

CompletedNCT03814668

Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution

Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution: Randomized, Double-blind, Placebo-controlled, Positive-controlled, Three-way Crossover, Acute Lactose Challenge

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Danisco · Industry
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

Study objectives: Primary: Difference in breath hydrogen concentration (BHC, ppm) in lactase and probiotic groups compared to placebo, measured by the incremental area under curve (iAUC) analysis Non-inferiority in breath hydrogen concentration (BHC, ppm) of probiotic group compared to lactase group, measured by the incremental area under curve (iAUC) analysis Secondary: Breath test * Breath hydrogen peak value (ppm) in lactase and probiotic groups compared to placebo * Cumulative breath hydrogen (ppm) in lactase and probiotic groups compared to placebo Acute gastrointestinal symptoms (severity or presence/absence to be defined on a Likert scale) in lactase and probiotic groups compared to placebo * Abdominal pain * Flatulence * Bloating * Nausea and vomiting * Bowel movements and diarrhea (if present, stool consistency to be defined on Bristol stool scale and number of bowel movements to be recorded) Ancillary: * Baseline fasting BHC (ppm) * Breath methane CH4 (ppm) * Breath carbon dioxide CO2 (ppm) * Probiotic identification in feces before each lactose challenge by molecular methods * Gene test to determine lactase deficiency status at screening (following SNP variants to be screened: 13910\*C (Europe, Central Asia, commonly used) -22018\*G (Europe), -13915\*T (Saudi-Arabia, Africa), -14010\*G (Africa), -13907\*C (Africa))

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticIntake of probiotic
DIETARY_SUPPLEMENTLactaseIntake of lactase
OTHERPlaceboIntake of placebo

Timeline

Start date
2018-11-05
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2019-01-24
Last updated
2019-08-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03814668. Inclusion in this directory is not an endorsement.